Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Experts Warn Covid-19 Wave Looming
Experts are warning about a new Covid-19 wave as 14 of New York City's wastewater treatment plants showed high levels of the disease in the past week.
Load More